Deltec Asset Management »

Theravance Biopharma shares owned by Deltec Asset Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Deltec Asset Management from 13F filings

Historical chart of Deltec Asset Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Deltec Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Deltec Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $255k 15k 17.00

More positions owned by Deltec Asset Management

Alphabet Inc - CL A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Doordash Inc Cl A Cl A (DASH)
Ocular Therapeutix (OCUL)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Carnival Corp Ltd Common Share Common Shares (CCL)
Flex Ord (FLEX)
Visa Inc - Class A Shares Com Cl A (V)
Alaska Air (ALK)
Capital One Financial (COF)
Meta Platforms Inc Cl A Cl A (META)
Uber Technologies (UBER)

View all positions for Deltec Asset Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors

View all funds holding Theravance Biopharma